Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Artery Disease: full-pipeline trial registry
28 of 51 indexed Peripheral Artery Disease trials are currently recruiting.
Corpus placement: #274 of 28,707 conditions by registered trial count.
51 US clinical trials · 28 currently recruiting · #274 of 28,707 conditions by registered trial count
Peripheral Artery Disease: 51 US clinical trials tracked, 28 recruiting.
Peripheral Artery Disease is the subject of 51 registered US clinical trials on ClinicalTrials.gov, 28 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 10 of these trials.
Enrollment posture brief
Registry condition peripheral-artery-disease
OPEN 28 | RECR 55% | LATE 6 | EARLY 9 | RANK #274 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Head and Neck Carcinoma (55% recruiting · 31 trials)
Peripheral Artery Disease lists 28 open slots (55% of 51 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Artery Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Artery Disease is recruiting above its size-band peers.
28 of 51 indexed trials (54.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Peripheral Artery Disease research.
Northwestern University accounts for 10 of 51 trials (19.6%). 30 distinct sponsors appear on at least one study for this condition label.
-
Typical Peripheral Artery Disease enrolment sits around 73 participants.
Median target enrolment is 73 among the 51 trials that report a genuine target (sentinel values excluded). 27 of those (52.9%) plan for fewer than 100 participants.
-
Peripheral Artery Disease research is mostly interventional.
46 interventional and 5 observational studies make up this index (90.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
| Phase 3 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Artery Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Artery Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Artery Disease page
51 registered trials, 28 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 28 Peripheral Artery Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Peripheral Artery Disease trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Artery Disease condition card totals 51 registered trials; most-linked intervention Exercise; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.